Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation.

@article{Charles2014MajorRT,
  title={Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation.},
  author={Julie Charles and J C B{\'e}ani and Giacomo Fiandrino and Benoit Busser},
  journal={Journal of the American Academy of Dermatology},
  year={2014},
  volume={71 3},
  pages={e97-9}
}